Dr. Loaiza-Bonilla is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
St. Luke's Cancer Care Associates Surgical Oncology - Allentown
240 Cetronia Rd, Ste 225
Allentown, PA 18104Phone+1 484-503-4673
Summary
- Dr. Arturo Loaiza-Bonilla is Systemwide Chief of Hematology and Oncology at St. Luke's University Health Network & Associate Professor of Medicine at the Lewis Katz SOM at Temple University
He also speaks multiple languages, including French, Spanish, Japanese. He specializes in cancer genetics, gastrointestinal cancer, experienced in immunotherapy, clinical research, AI, digital & global health.
Education & Training
University of PennsylvaniaMSEd, Medical Education, 2014 - 2016
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2010 - 2013
Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 2007 - 2010
MedStar Health Georgetown University/Harbor HospitalResidency, Internal Medicine, 2007 - 2010
National University of ColombiaClass of 2004
Certifications & Licensure
PA State Medical License 2013 - 2026
NJ State Medical License 2022 - 2025
GA State Medical License 2021 - 2022
FL State Medical License Active through 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top 40 Under 40 Philadelphia Business Journal, 2018
- Castle Connolly Top Doctor Recognition Castle Connolly, 2018
- President Elect Pennsylvania Society of Oncology and Hematology, 2018
- Join now to see all
Clinical Trials
- A Study of TAS-120 in Patients With Advanced Solid Tumors Start of enrollment: 2014 Jul 21
- TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer Start of enrollment: 2016 Mar 14
- Determine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic Cancer Start of enrollment: 2017 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Achieving white blood cell equity: are the safety profiles of biosimilar and reference pegfilgrastims comparable?Arturo Loaiza-Bonilla, Ray D Page
Future Oncology. 2024-01-01 - 7 citationsClinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US:Ran Jin, Reshma Mahtani, Neil A. Accortt, Tatiana Lawrence, Darcie Sandschafer
Therapeutic Advances in Medical Oncology. 2021-09-01 - 2 citationsConcurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer.William Tristram Arscott, Kevin T. Nead, Adham S. Bear, Sriram Venigalla, Jacob E. Shabason
American Journal of Clinical Oncology. 2021-09-01
Press Mentions
Exploring the Impact of AI Technologies on Oncology PracticeFebruary 14th, 2025- Addition of AI to Mammogram Screenings Bolsters Cancer Detection RatesFebruary 13th, 2025
- The Rise of Large Language Models in Medicine: The Next FrontierJanuary 24th, 2025
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
- Member
Other Languages
- French, Spanish, Japanese
External Links
- LinkedInhttps://www.linkedin.com/in/arturoloaizabonillla
- CTCA websitehttps://www.cancercenter.com/eastern/doctors-and-clinicians/arturo-loaiza-bonilla/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
